Close Menu

"The publication in this issue of the research paper 'Airborne transmission of influenza A/H5N1 virus between ferrets,' plus its newer companion 'The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host,' marks the end of more than eight months of widely reported controversy over whether some of the data now freely accessible should be withheld in the public interest,"

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.